TOP STORIES

• REGULATORY First Generics for 5 APIs Join NHI Price List, Main Targets Are Nexium/Lexapro
  December 9, 2022

• REGULATORY Industry Prods Special Inflation Measure in Off Year, Payers Don’t See Much Need: Chuikyo Hearing
  December 8, 2022

• ORGANIZATION FPMAJ Poll Finds Worsening Supply Woes with 28% of Drugs Restricted or Suspended
  December 7, 2022

• ACADEMIA Lewy Body Dementia Specialist Sees Aricept Approval Modification as Positive Move
  December 6, 2022

• REGULATORY NHI-Market Price Gap Narrowed, but Chuikyo Payer Reps Say Normal Revision Possible
  December 5, 2022

• REGULATORY Average NHI-Market Price Gap for 2023 Off-Year Revision at 7.0%: MHLW
  December 2, 2022

• BUSINESS AstraZeneca Japan Set to Buttress Respiratory Business with Tezspire Debut
  December 2, 2022

• BUSINESS Ultragenyx to Ramp Up Ultra-Orphan Drug Development, Bolster Hiring in Japan
  December 1, 2022

• BUSINESS Eisai Says 2 Trial Deaths Not Attributed to Lecanemab, No Change in Submission Plan
  December 1, 2022

• REGULATORY MOF Panel Presses for Full Annual Price Cuts, Rethink of COVID-Related Government Purchase
  November 30, 2022

• BUSINESS No Direct Causal Link between Lecanemab and Death in Clinical Trial: Eisai
  November 30, 2022

• REGULATORY Orlistat in Line for Approval as Japan’s 1st Nonprescription Obesity Drug after 4-Year Review
  November 29, 2022

• COMMENTARY Japan Should Hone Emergency Approval Scheme Based on Xocova Example
  November 28, 2022

• BUSINESS Shionogi Chief Defends Xocova Data, Eager to Prove Benefits in Clinical Settings
  November 25, 2022

• REGULATORY Japan Grants 1st Emergency Approval to Shionogi COVID Pill Xocova
  November 24, 2022

• COMMENTARY Pharma Industry Stays Pat on “No” to Off-Year Plan, Why Not Going for Trade-Off?
  November 22, 2022

• ACADEMIA Academic Societies Warn against Hoarding Meropenem as Supply Crunch Intensifies
  November 21, 2022

• BUSINESS Big 3 Generic Firms Struggle in H1; Nichi-Iko Logs Excess Debt as Profits Tank for Rivals
  November 18, 2022

• BUSINESS Merck R&D Chief Confident on Expanding Pipeline towards Keytruda Patent Cliff and Beyond
  November 17, 2022

• BUSINESS Top 4 Wholesalers on Recovery Trend, Operating Profit Up 69.1% in April-September
  November 16, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• …
• Next ›
• 最終 »